SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · Three top executives at United Therapeutics, the CEO, CFO, and General…

UNITED THERAPEUTICS Corp · CLUSTER filed Apr 2, 2026 at 16:36 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Apr 2, 2026 at 16:36 ET

Three top executives at United Therapeutics, the CEO, CFO, and General Counsel, sold a combined $376K in shares over a 7-day window, following the exercise of stock options. The sales represent less than 0.0015% of the company's $24.8B market cap and appear to be part of pre-planned, non-discretionary transactions following option exercises.

  • CEO Martine Rothblatt sold $21.7K, CFO James Edgemon sold $66.3K, and General Counsel Paul Mahon sold $288K in open-market transactions.
  • All sales followed the exercise of stock options, with significant non-cash derivative exercises totaling over $5.4M in option value realized.
  • Total dollar value of open-market sales ($376K) is only 0.0015% of the company's $24.8B market cap.
  • Sales occurred at prices between $551.86 and $560.30 per share.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access